FI
ELV icon

Fosun International’s Elevance Health ELV Stock Holding History

Fosun International’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-410
Closed -$222K – 53
2024
Q2 		$222K Hold
410
– – 0.08% 45
2024
Q1 		$213K Sell
410
-410
-50% -$204K 0.07% 44
2023
Q4 		$387K Sell
820
-380
-32% -$176K 0.08% 42
2023
Q3 		$523K Buy
1,200
+500
+71% +$227K 0.08% 51
2023
Q2 		$311K Hold
700
– – 0.04% 56
2023
Q1 		$322K Buy
700
+150
+27% +$71.4K 0.03% 59
2022
Q4 		$282K Buy
+550
New +$279K 0.02% 63
2019
Q1 		– Sell
-3,510
Closed -$916K – 322
2018
Q4 		$916K Buy
+3,510
New +$965K 0.05% 140

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fosun International's ELV Position: Q3 2024 in Review

Fosun International sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 410 shares — an estimated $222K sold.

Fosun International first reported a position in ELV in Q4 2018 and held it in 8 quarters. The position peaked at $916K in Q4 2018. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Fosun International reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Fosun International sold 410 Elevance Health shares in Q3 2024, an estimated $222K.
  • Fosun International first reported a position in Elevance Health in Q4 2018 and held it in 8 quarters.
  • Fosun International's Elevance Health position peaked at $916K in Q4 2018.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Fosun International's 13F filing for Q3 2024, filed 14 Nov 2024.